loadpatents
name:-0.0016028881072998
name:-0.022546052932739
name:-0.00049614906311035
Junge; Bodo Patent Filings

Junge; Bodo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Junge; Bodo.The latest application filed is for "phenyl-substituted 1,4-dihydropyridines".

Company Profile
0.20.1
  • Junge; Bodo - Wuppertal DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Phenyl-substituted 1,4-dihydropyridines
Grant 6,630,494 - Meier , et al. October 7, 2
2003-10-07
Phenyl-substituted 1,4-dihydropyridines
App 20010034451 - Meier, Heinrich ;   et al.
2001-10-25
Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
Grant 6,194,428 - Urbahns , et al. February 27, 2
2001-02-27
Dioxo-thiopyrano-pyridine-carboxylic acid derivatives and their use as medicaments
Grant 5,756,515 - Urbahns , et al. May 26, 1
1998-05-26
Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders
Grant 5,670,525 - Urbahns , et al. September 23, 1
1997-09-23
Method for treating depression using substituted aminomethyltetralins and their heterocyclic analogues
Grant 5,506,246 - Junge , et al. April 9, 1
1996-04-09
2-aminomethyl-chromans
Grant 5,468,882 - Schohe-Loop , et al. November 21, 1
1995-11-21
Piperidylmethyl-substituted chroman derivatives
Grant 5,326,771 - Heine , et al. July 5, 1
1994-07-05
2-aminomethyl-chromans
Grant 5,318,988 - Schohe-Loop , et al. June 7, 1
1994-06-07
Substituted aminomethyltetralins and their heterocyclic analogues
Grant 5,300,523 - Junge , et al. April 5, 1
1994-04-05
Substituted aminomethyltetralins and their heterocyclic analogues
Grant 5,137,901 - Junge , et al. August 11, 1
1992-08-11
Methods for treating viruses in patients by administering 2-hydroxymethylene-3,4,5-trihydroxypiperidines
Grant 5,051,407 - Boshagen , et al. September 24, 1
1991-09-24
N-substituted derivatives of 1-desoxynojirimycin and 1-desoxymannonojirimycin and pharmaceutical use
Grant 4,940,705 - Boshagen , et al. July 10, 1
1990-07-10
Substituted amino-5,6,7,8-tetrahydronaphthyl-oxyacetic acids, processes for their preparation and their use as medicaments
Grant 4,921,998 - Niewohner , et al. May 1, 1
1990-05-01
8-Substituted 2-aminotetralins
Grant 4,873,262 - Junge , et al. October 10, 1
1989-10-10
N-glycosylated carboxylic acid derivatives as agents for combating rheumatic diseases
Grant 4,710,491 - Lockhoff , et al. December 1, 1
1987-12-01
Antidiabetic 3,4,5-trihydroxypiperidines
Grant 4,639,436 - Junge , et al. January 27, 1
1987-01-27
Pyridoindole derivatives, compositions and use
Grant 4,564,613 - Boltze , et al. January 14, 1
1986-01-14
1-Alka-2,4-dienyl-2-hydroxymethyl-3,4,5-trihydroxypiperidines as inhibitors of .alpha.-glucoside hydrolases
Grant 4,312,872 - Junge , et al. January 26, 1
1982-01-26
Animal feedstuffs employing 3,4,5-trihydroxypiperidines
Grant 4,260,622 - Junge , et al. April 7, 1
1981-04-07
Amino sugar derivatives
Grant 4,062,950 - Frommer , et al. December 13, 1
1977-12-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed